Skip to main content
. 2017 Apr 1;47(2):94–105. doi: 10.4274/tjo.80688

Figure 5. A 61-year-old female patient with infiltrative thyroid-associated ophthalmopathy. The patient exhibted significant palpebral and conjunctival edema and reported severe pain (A). The same patient showed substantial regression of clinical signs after 3 months of intravenous corticosteroid therapy (B).

Figure 5